{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [
    {
      "AbstractText": [
        "Estimer le ratio de l\u00e9talit\u00e9 r\u00e9el de la maladie \u00e0 coronavirus 2019 (COVID-19) \u00e0 partir des donn\u00e9es de s\u00e9ropr\u00e9valence.",
        "J'ai effectu\u00e9 des recherches sur PubMed et sur les serveurs de pr\u00e9publication afin de trouver des \u00e9tudes consacr\u00e9es \u00e0 la s\u00e9ropr\u00e9valence de la COVID-19, avec des \u00e9chantillons \u2265 500, au 9 septembre 2020. J'ai \u00e9galement pr\u00e9lev\u00e9 des r\u00e9sultats suppl\u00e9mentaires d\u00e9riv\u00e9s d'\u00e9tudes nationales qui figurent dans les versions pr\u00e9liminaires de divers rapports et communiqu\u00e9s de presse. J'ai analys\u00e9 les \u00e9tudes pour y d\u00e9celer des caract\u00e9ristiques de conception et des estimations de s\u00e9ropr\u00e9valence. Ensuite, j'ai calcul\u00e9 le ratio de l\u00e9talit\u00e9 r\u00e9el pour chaque \u00e9tude en divisant le nombre cumul\u00e9 de d\u00e9c\u00e8s dus \u00e0 la COVID-19 par le nombre d'individus qui auraient \u00e9t\u00e9 infect\u00e9s dans chaque r\u00e9gion. Enfin, j'ai apport\u00e9 des corrections en fonction des types d'anticorps test\u00e9s (immunoglobulines, IgG, IgM, IgA).",
        "J'ai pris 61 \u00e9tudes en compte (74 estimations) et huit estimations nationales pr\u00e9liminaires. Les estimations en mati\u00e8re de s\u00e9ropr\u00e9valence \u00e9taient comprises entre 0,02% et 53,40%. Les ratios de l\u00e9talit\u00e9 r\u00e9els allaient de 0,00% \u00e0 1,63%, les valeurs corrig\u00e9es de 0,00% \u00e0 1,54%. Dans les 51 lieux \u00e9tudi\u00e9s, la m\u00e9diane du ratio de l\u00e9talit\u00e9 r\u00e9el pour la COVID-19 s'\u00e9levait \u00e0 0,27% (0,23% apr\u00e8s correction): le ratio \u00e9tait de 0,09% dans les endroits o\u00f9 le taux de mortalit\u00e9 d\u00fb \u00e0 la COVID-19 \u00e9tait inf\u00e9rieur \u00e0 la moyenne mondiale (< 118 d\u00e9c\u00e8s/million d'habitants), de 0,20% dans les endroits d\u00e9nombrant 118\u2013500 d\u00e9c\u00e8s COVID-19/million d'habitants, et de 0,57% l\u00e0 o\u00f9 la COVID-19 \u00e9tait responsable de > 500 d\u00e9c\u00e8s/million d'habitants. Chez les personnes de moins de 70 ans, les ratios de l\u00e9talit\u00e9 r\u00e9els se situaient entre 0,00% et 0,31% avec des m\u00e9dianes brutes et corrig\u00e9es de 0,05%.",
        "Le ratio de l\u00e9talit\u00e9 r\u00e9el de la COVID-19 peut consid\u00e9rablement varier d'un endroit \u00e0 l'autre, ce qui pourrait correspondre aux diff\u00e9rences de structure de pyramide des \u00e2ges au sein de la population, au case-mix entre patients infect\u00e9s et d\u00e9c\u00e9d\u00e9s, ainsi qu'\u00e0 d'autres facteurs. Les ratios de l\u00e9talit\u00e9 r\u00e9els que j'ai pu d\u00e9duire avaient tendance \u00e0 \u00eatre nettement inf\u00e9rieurs aux estimations formul\u00e9es pr\u00e9c\u00e9demment durant la pand\u00e9mie."
      ],
      "CopyrightInformation": "(c) 2021 The authors; licensee World Health Organization."
    },
    {
      "AbstractText": [
        "Estimar la tasa de letalidad por la infecci\u00f3n de la enfermedad por coronavirus de 2019 (COVID-19) a partir de los datos de seroprevalencia.",
        "Se buscaron los estudios de seroprevalencia de la COVID-19 con un tama\u00f1o de muestra mayor o igual a 500 a partir del 9 de septiembre de 2020 en PubMed y en los servidores de preimpresi\u00f3n. Adem\u00e1s, se recuperaron los resultados adicionales de los estudios nacionales a partir de los comunicados de prensa y de los informes preliminares. Se evaluaron los estudios para determinar las caracter\u00edsticas de dise\u00f1o y las estimaciones de seroprevalencia. Para calcular la tasa de letalidad por la infecci\u00f3n de cada estudio, se dividi\u00f3 la cantidad acumulada de muertes por la COVID-19 por la cantidad de personas que se estima que est\u00e1n infectadas en cada regi\u00f3n. Asimismo, se corrigi\u00f3 la cantidad de tipos de anticuerpos probados (inmunoglobulinas, IgG, IgM, IgA).",
        "Se incluyeron 61 estudios (74 estimaciones) y 8 estimaciones nacionales preliminares. Las estimaciones de seroprevalencia oscilaban entre el 0,02\u00a0% y el 53,40\u00a0%. Las tasas de letalidad por la infecci\u00f3n oscilaron entre el 0,00\u00a0% y el 1,63\u00a0%, los valores corregidos entre el 0,00\u00a0% y el 1,54\u00a0%. En 51 lugares, la mediana de la tasa de letalidad por la infecci\u00f3n de la COVID-19 fue del 0,27\u00a0% (corregida en un 0,23\u00a0%): la tasa fue del 0,09\u00a0% en lugares donde las tasas de letalidad de la poblaci\u00f3n con la COVID-19 eran inferiores al promedio mundial (menos de\u00a0118 muertes/mill\u00f3n), del 0,20\u00a0% en lugares con 118-500 muertes a causa de la COVID-19/mill\u00f3n de personas y del 0,57\u00a0% en lugares con m\u00e1s de\u00a0500 muertes a causa de la COVID-19/mill\u00f3n de personas. En personas menores de 70 a\u00f1os, las tasas de letalidad por la infecci\u00f3n oscilaron entre el 0,00\u00a0% y el 0,31\u00a0% con medianas brutas y corregidas del 0,05\u00a0%.",
        "La tasa de letalidad por infecci\u00f3n de la COVID-19 puede variar de manera sustancial en diferentes lugares y esto puede reflejar diferencias en la estructura de edad de la poblaci\u00f3n y en la variedad de casos de los pacientes infectados y fallecidos, as\u00ed como en otros factores. Las tasas de letalidad por infecci\u00f3n que se calculan tienden a ser mucho m\u00e1s bajas que las estimaciones realizadas a principios de la pandemia."
      ],
      "CopyrightInformation": "(c) 2021 The authors; licensee World Health Organization."
    },
    {
      "AbstractText": [
        "\u0627\u0644\u063a\u0631\u0636 \u062a\u0642\u062f\u064a\u0631 \u0645\u0639\u062f\u0644 \u0627\u0644\u0648\u0641\u064a\u0627\u062a \u0627\u0644\u0646\u0627\u062c\u0645\u0629 \u0639\u0646 \u0627\u0644\u0625\u0635\u0627\u0628\u0629 \u0628\u0645\u0631\u0636 \u0641\u064a\u0631\u0648\u0633 \u0643\u0648\u0631\u0648\u0646\u0627 2019 (\u0643\u0648\u0641\u064a\u062f 19) \u0645\u0646 \u0628\u064a\u0627\u0646\u0627\u062a \u0627\u0644\u0627\u0646\u062a\u0634\u0627\u0631 \u0627\u0644\u0645\u0635\u0644\u064a. \u0627\u0644\u0637\u0631\u064a\u0642\u0629 \u0642\u0645\u062a \u0628\u0627\u0644\u0628\u062d\u062b \u0641\u064a \u062e\u0648\u0627\u062f\u0645 PubMed \u0648\u062e\u0648\u0627\u062f\u0645 \u0645\u0627 \u0642\u0628\u0644 \u0627\u0644\u0637\u0628\u0627\u0639\u0629 \u0639\u0646 \u062f\u0631\u0627\u0633\u0627\u062a \u0627\u0644\u0627\u0646\u062a\u0634\u0627\u0631 \u0627\u0644\u0645\u0635\u0644\u064a \u0644\u0643\u0648\u0641\u064a\u062f 19\u060c \u0628\u062d\u062c\u0645 \u0639\u064a\u0646\u0629 \u0623\u0643\u0628\u0631 \u0645\u0646 \u0623\u0648 \u062a\u0633\u0627\u0648\u064a 500 \u0628\u062f\u0621\u0627\u064b \u0645\u0646 9 \u0633\u0628\u062a\u0645\u0628\u0631/\u0623\u064a\u0644\u0648\u0644 2020. \u0643\u0645\u0627 \u0623\u0646\u0646\u064a \u0627\u0633\u062a\u0631\u062c\u0639\u062a \u0627\u0644\u0646\u062a\u0627\u0626\u062c \u0627\u0644\u0625\u0636\u0627\u0641\u064a\u0629 \u0644\u0644\u062f\u0631\u0627\u0633\u0627\u062a \u0627\u0644\u0648\u0637\u0646\u064a\u0629 \u0645\u0646 \u0627\u0644\u0628\u064a\u0627\u0646\u0627\u062a \u0627\u0644\u0635\u062d\u0641\u064a\u0629 \u0648\u0627\u0644\u062a\u0642\u0627\u0631\u064a\u0631 \u0627\u0644\u0623\u0648\u0644\u064a\u0629. \u0642\u0645\u062a \u0628\u062a\u0642\u064a\u064a\u0645 \u062f\u0631\u0627\u0633\u0627\u062a \u0645\u064a\u0632\u0627\u062a \u0627\u0644\u062a\u0635\u0645\u064a\u0645 \u0648\u062a\u0642\u062f\u064a\u0631\u0627\u062a \u0627\u0644\u0627\u0646\u062a\u0634\u0627\u0631 \u0627\u0644\u0645\u0635\u0644\u064a. \u0644\u0642\u062f \u0642\u0645\u062a \u0628\u062a\u0642\u062f\u064a\u0631 \u0645\u0639\u062f\u0644 \u0627\u0644\u0648\u0641\u064a\u0627\u062a \u0627\u0644\u0646\u0627\u062c\u0645\u0629 \u0639\u0646 \u0627\u0644\u0625\u0635\u0627\u0628\u0629 \u0644\u0643\u0644 \u062f\u0631\u0627\u0633\u0629 \u0639\u0646 \u0637\u0631\u064a\u0642 \u0642\u0633\u0645\u0629 \u0627\u0644\u0639\u062f\u062f \u0627\u0644\u0625\u062c\u0645\u0627\u0644\u064a \u0644\u0644\u0648\u0641\u064a\u0627\u062a \u0627\u0644\u0646\u0627\u062a\u062c\u0629 \u0639\u0646 \u062c\u0627\u0626\u062d\u0629 \u0643\u0648\u0641\u064a\u062f 19\u060c \u0639\u0644\u0649 \u0639\u062f\u062f \u0627\u0644\u0623\u0634\u062e\u0627\u0635 \u0627\u0644\u0645\u0642\u062f\u0631 \u0625\u0635\u0627\u0628\u062a\u0647\u0645 \u0641\u064a \u0643\u0644 \u0645\u0646\u0637\u0642\u0629. \u0648\u0642\u0645\u062a \u0628\u062a\u0635\u062d\u064a\u062d \u0639\u062f\u062f \u0623\u0646\u0648\u0627\u0639 \u0627\u0644\u0623\u062c\u0633\u0627\u0645 \u0627\u0644\u0645\u0636\u0627\u062f\u0629 \u0627\u0644\u062a\u064a \u062a\u0645 \u0627\u062e\u062a\u0628\u0627\u0631\u0647\u0627 (\u0627\u0644\u063a\u0644\u0648\u0628\u064a\u0646 \u0627\u0644\u0645\u0646\u0627\u0639\u064a\u060c IgG \u060c IgM \u060c IgA). \u0627\u0644\u0646\u062a\u0627\u0626\u062c \u0642\u0645\u062a \u0628\u062a\u0636\u0645\u064a\u0646 61 \u062f\u0631\u0627\u0633\u0629 (74 \u062a\u0642\u062f\u064a\u0631\u064b\u0627) \u0648\u062b\u0645\u0627\u0646\u064a\u0629 \u062a\u0642\u062f\u064a\u0631\u0627\u062a \u0648\u0637\u0646\u064a\u0629 \u0623\u0648\u0644\u064a\u0629. \u062a\u0631\u0627\u0648\u062d\u062a \u062a\u0642\u062f\u064a\u0631\u0627\u062a \u0627\u0644\u0627\u0646\u062a\u0634\u0627\u0631 \u0627\u0644\u0645\u0635\u0644\u064a \u0645\u0646 0.02% \u0625\u0644\u0649 53.40%. \u062a\u0631\u0627\u0648\u062d\u062a \u0645\u0639\u062f\u0644\u0627\u062a \u0648\u0641\u064a\u0627\u062a \u0627\u0644\u0639\u062f\u0648\u0649 \u0645\u0646 0.00% \u0625\u0644\u0649 1.63%\u060c \u0648\u062a\u0645 \u062a\u0635\u062d\u064a\u062d \u0627\u0644\u0642\u064a\u0645 \u0645\u0646 0.00% \u0625\u0644\u0649 1.54%. \u0639\u0628\u0631 51 \u0645\u0648\u0642\u0639\u064b\u0627\u060c \u0643\u0627\u0646 \u0645\u062a\u0648\u0633\u0637 \u200b\u200b\u0645\u0639\u062f\u0644 \u0648\u0641\u064a\u0627\u062a \u0639\u062f\u0648\u0649 \u0643\u0648\u0641\u064a\u062f 19 \u0647\u0648 0.27% (\u062a\u0635\u062d\u064a\u062d \u0628\u0646\u0633\u0628\u0629 0.23%): \u0643\u0627\u0646 \u0627\u0644\u0645\u0639\u062f\u0644 0.09% \u0641\u064a \u0627\u0644\u0645\u0648\u0627\u0642\u0639 \u0627\u0644\u062a\u064a \u062a\u0642\u0644 \u0641\u064a\u0647\u0627 \u0645\u0639\u062f\u0644\u0627\u062a \u0648\u0641\u064a\u0627\u062a \u0627\u0644\u0633\u0643\u0627\u0646 \u0627\u0644\u0645\u0635\u0627\u0628\u064a\u0646 \u0628\u0643\u0648\u0641\u064a\u062f 19 \u0639\u0646 \u0627\u0644\u0645\u062a\u0648\u0633\u0637 \u200b\u200b\u0627\u0644\u0639\u0627\u0644\u0645\u064a (\u0623\u0643\u062b\u0631 \u0645\u0646 118 \u062d\u0627\u0644\u0629 \u0648\u0641\u0627\u0629/\u0645\u0644\u064a\u0648\u0646 \u0646\u0633\u0645\u0629)\u060c \u06480.20% \u0641\u064a \u0627\u0644\u0645\u0648\u0627\u0642\u0639 \u0627\u0644\u062a\u064a \u064a\u0648\u062c\u062f \u0628\u0647\u0627 \u0645\u0646 118 \u0625\u0644\u0649 500 \u062d\u0627\u0644\u0629 \u0648\u0641\u0627\u0629/\u0645\u0644\u064a\u0648\u0646 \u0646\u0633\u0645\u0629 \u0645\u0635\u0627\u0628\u064a\u0646 \u0628\u0643\u0648\u0641\u064a\u062f 19\u060c \u06480.57% \u0641\u064a \u0645\u0648\u0627\u0642\u0639 \u0628\u0647\u0627 \u0623\u0643\u062b\u0631 \u0645\u0646 500 \u062d\u0627\u0644\u0629 \u0648\u0641\u0627\u0629/\u0645\u0644\u064a\u0648\u0646 \u0646\u0633\u0645\u0629 \u0628\u0633\u0628\u0628 \u0643\u0648\u0641\u064a\u062f 19. \u0641\u064a \u0627\u0644\u0623\u0634\u062e\u0627\u0635 \u0627\u0644\u0630\u064a\u0646 \u062a\u0642\u0644 \u0623\u0639\u0645\u0627\u0631\u0647\u0645 \u0639\u0646 70 \u0639\u0627\u0645\u064b\u0627\u060c \u062a\u0631\u0627\u0648\u062d\u062a \u0645\u0639\u062f\u0644\u0627\u062a \u0648\u0641\u064a\u0627\u062a \u0627\u0644\u0625\u0635\u0627\u0628\u0629 \u0628\u0627\u0644\u0639\u062f\u0648\u0649 \u0645\u0646 0.00% \u0625\u0644\u0649 0.31% \u0628\u0645\u062a\u0648\u0633\u0637\u0627\u062a \u0645\u0628\u062f\u0626\u064a\u0629 \u0648\u0645\u0635\u062d\u062d\u0629 \u0642\u062f\u0631\u0647\u0627 0.05%. \u0627\u0644\u0627\u0633\u062a\u0646\u062a\u0627\u062c \u064a\u0645\u0643\u0646 \u0623\u0646 \u064a\u062e\u062a\u0644\u0641 \u0645\u0639\u062f\u0644 \u0648\u0641\u064a\u0627\u062a \u0627\u0644\u0625\u0635\u0627\u0628\u0629 \u0628\u0641\u064a\u0631\u0648\u0633 \u0643\u0648\u0641\u064a\u062f 19 \u0628\u0634\u0643\u0644 \u0643\u0628\u064a\u0631 \u0639\u0628\u0631 \u0627\u0644\u0645\u0648\u0627\u0642\u0639 \u0627\u0644\u0645\u062e\u062a\u0644\u0641\u0629\u060c \u0648\u0642\u062f \u064a\u0639\u0643\u0633 \u0647\u0630\u0627 \u0627\u0644\u0627\u062e\u062a\u0644\u0627\u0641\u0627\u062a \u0641\u064a \u0627\u0644\u062a\u0631\u0643\u064a\u0628 \u0627\u0644\u0639\u0645\u0631\u064a \u0644\u0644\u0633\u0643\u0627\u0646\u060c \u0648\u0645\u0632\u064a\u062c \u0627\u0644\u062d\u0627\u0644\u0627\u062a \u0645\u0646 \u0627\u0644\u0645\u0631\u0636\u0649 \u0627\u0644\u0645\u0635\u0627\u0628\u064a\u0646 \u0648\u0627\u0644\u0645\u062a\u0648\u0641\u064a\u0646\u060c \u0648\u0639\u0648\u0627\u0645\u0644 \u0623\u062e\u0631\u0649. \u062a\u0645\u064a\u0644 \u0645\u0639\u062f\u0644\u0627\u062a \u0627\u0644\u0648\u0641\u064a\u0627\u062a \u0627\u0644\u0645\u0633\u062a\u062f\u0644 \u0639\u0646\u0647\u0627 \u0645\u0646 \u0627\u0644\u0639\u062f\u0648\u0649 \u0625\u0644\u0649 \u0623\u0646 \u062a\u0643\u0648\u0646 \u0623\u0642\u0644 \u0628\u0643\u062b\u064a\u0631 \u0645\u0646 \u0627\u0644\u062a\u0642\u062f\u064a\u0631\u0627\u062a \u0627\u0644\u062a\u064a \u062a\u0645 \u0625\u062c\u0631\u0627\u0624\u0647\u0627 \u0641\u064a \u0648\u0642\u062a \u0633\u0627\u0628\u0642 \u0641\u064a \u0627\u0644\u062c\u0627\u0626\u062d\u0629."
      ],
      "CopyrightInformation": "(c) 2021 The authors; licensee World Health Organization."
    },
    {
      "AbstractText": [
        "\u6839\u636e\u8840\u6e05\u9633\u6027\u7387\u6570\u636e\u4f30\u8ba1 2019 \u5e74\u51a0\u72b6\u75c5\u6bd2\u75c5\uff08\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\u80ba\u708e\uff09\u7684\u611f\u67d3\u6b7b\u4ea1\u7387\u3002.",
        "\u5728 PubMed \u548c\u9884\u5370\u672c\u670d\u52a1\u5668\u4e0a\u67e5\u627e\u622a\u81f3 2020 \u5e74 9 \u6708 9 \u65e5\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\u80ba\u708e\u76f8\u5173\u7684\u8840\u6e05\u9633\u6027\u7387\u7814\u7a76\uff0c\u6837\u672c\u91cf\u4e3a\u2009500 \u4e2a\u3002\u53e6\u5916\u6839\u636e\u521d\u6b65\u65b0\u95fb\u7a3f\u548c\u62a5\u544a\u68c0\u7d22\u4e86\u5176\u4ed6\u5168\u56fd\u6027\u7814\u7a76\u7ed3\u679c\u3002\u5e76\u8bc4\u4f30\u4e86\u4e0e\u8bbe\u8ba1\u7279\u5f81\u548c\u8840\u6e05\u9633\u6027\u7387\u4f30\u8ba1\u503c\u76f8\u5173\u7684\u7814\u7a76\u3002\u901a\u8fc7\u5c06\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\u80ba\u708e\u7d2f\u8ba1\u6b7b\u4ea1\u4eba\u6570\u9664\u4ee5\u6bcf\u4e2a\u5730\u533a\u4f30\u8ba1\u611f\u67d3\u4eba\u6570\uff0c\u4f30\u7b97\u51fa\u4e86\u6bcf\u9879\u7814\u7a76\u7684\u611f\u67d3\u6b7b\u4ea1\u7387\u3002\u7136\u540e\u6821\u6b63\u4e86\u6d4b\u8bd5\u7684\u6297\u4f53\u7c7b\u578b\uff08\u514d\u75ab\u7403\u86cb\u767d\u3001\u514d\u75ab\u7403\u86cb\u767d G\u3001\u514d\u75ab\u7403\u86cb\u767d M\u3001\u514d\u75ab\u7403\u86cb\u767d A\uff09\u7684\u6570\u91cf\u3002.",
        "\u6211\u6c47\u603b\u4e86 61 \u9879\u7814\u7a76\uff0874 \u4e2a\u4f30\u8ba1\u503c\uff09\u548c 8 \u4e2a\u5168\u56fd\u6027\u521d\u6b65\u4f30\u8ba1\u503c\u3002\u8840\u6e05\u9633\u6027\u7387\u4f30\u8ba1\u503c\u4ecb\u4e8e 0.02\uff05 \u81f3 53.40\uff05 \u4e4b\u95f4\u3002\u611f\u67d3\u6b7b\u4ea1\u7387\u4ecb\u4e8e 0.00\uff05 \u81f3 1.63\uff05 \u4e4b\u95f4\uff0c\u6821\u6b63\u503c\u5219\u4ecb\u4e8e 0.00\uff05 \u81f3 1.54\uff05 \u4e4b\u95f4\u3002\u5728 51 \u4e2a\u5730\u533a\u4e2d\uff0c\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\u80ba\u708e\u611f\u67d3\u6b7b\u4ea1\u7387\u7684\u4e2d\u4f4d\u6570\u4e3a 0.27\uff05\uff08\u6821\u6b63\u503c\u4e3a 0.23\uff05\uff09\uff1a\u5728\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\u80ba\u708e\u5bfc\u81f4\u7684\u4eba\u53e3\u6b7b\u4ea1\u7387\u4f4e\u4e8e\u5168\u7403\u5e73\u5747\u6c34\u5e73\uff08\u6bcf\u4e00\u767e\u4e07\u4eba\u53e3\u4e2d\u6b7b\u4ea1\u75c5\u4f8b\u5c0f\u4e8e 118 \u4f8b\uff09\u7684\u5730\u533a\u4e2d\uff0c\u8be5\u6bd4\u7387\u4e3a 0.09\uff05\uff1b\u5728\u6bcf\u4e00\u767e\u4e07\u4eba\u53e3\u4e2d\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\u80ba\u708e\u6b7b\u4ea1\u75c5\u4f8b\u4ecb\u4e8e 118\u2013500 \u4f8b\u4e4b\u95f4\u7684\u5730\u533a\uff0c\u8be5\u6bd4\u7387\u4e3a 0.20\uff05\uff1b\u800c\u5728\u6bcf\u4e00\u767e\u4e07\u4eba\u53e3\u4e2d\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\u80ba\u708e\u6b7b\u4ea1\u75c5\u4f8b\u5927\u4e8e 500 \u4f8b\u7684\u5730\u533a\uff0c\u8be5\u6bd4\u7387\u5219\u4e3a 0.57\uff05\u300270 \u5c81\u4ee5\u4e0b\u4eba\u7fa4\u7684\u611f\u67d3\u6b7b\u4ea1\u7387\u4ecb\u4e8e 0.00\uff05 \u81f3 0.31\uff05 \u4e4b\u95f4\uff0c\u7ecf\u7c97\u7565\u6821\u6b63\u540e\u8be5\u6bd4\u7387\u7684\u4e2d\u4f4d\u6570\u4e3a 0.05\uff05\u3002.",
        "\u4e0d\u540c\u5730\u533a\u7684\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\u80ba\u708e\u611f\u67d3\u6b7b\u4ea1\u7387\u53ef\u80fd\u5b58\u5728\u5f88\u5927\u7684\u5dee\u5f02\uff0c\u636e\u6b64\u53ef\u53cd\u6620\u51fa\u5728\u4eba\u53e3\u5e74\u9f84\u7ed3\u6784\u3001\u611f\u67d3\u548c\u6b7b\u4ea1\u75c5\u4f8b\u7ec4\u5408\u4ee5\u53ca\u5176\u4ed6\u56e0\u7d20\u65b9\u9762\u5b58\u5728\u5dee\u5f02\u3002\u63a8\u65ad\u7684\u611f\u67d3\u6b7b\u4ea1\u7387\u5f80\u5f80\u6bd4\u5168\u7403\u6027\u6d41\u884c\u75c5\u7206\u53d1\u521d\u671f\u7684\u4f30\u8ba1\u503c\u8981\u4f4e\u5f97\u591a\u3002."
      ],
      "CopyrightInformation": "(c) 2021 The authors; licensee World Health Organization."
    },
    {
      "AbstractText": [
        "\u041e\u0446\u0435\u043d\u0438\u0442\u044c \u043f\u043e\u043a\u0430\u0437\u0430\u0442\u0435\u043b\u044c \u043b\u0435\u0442\u0430\u043b\u044c\u043d\u043e\u0441\u0442\u0438 \u043f\u0440\u0438 \u0438\u043d\u0444\u0438\u0446\u0438\u0440\u043e\u0432\u0430\u043d\u0438\u0438 \u043a\u043e\u0440\u043e\u043d\u0430\u0432\u0438\u0440\u0443\u0441\u043d\u044b\u043c \u0437\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u043d\u0438\u0435\u043c 2019\u00a0\u0433.\u00a0(COVID-19) \u043d\u0430 \u043e\u0441\u043d\u043e\u0432\u0430\u043d\u0438\u0438 \u0434\u0430\u043d\u043d\u044b\u0445 \u043e \u0441\u0435\u0440\u043e\u0440\u0430\u0441\u043f\u0440\u043e\u0441\u0442\u0440\u0430\u043d\u0435\u043d\u043d\u043e\u0441\u0442\u0438.",
        "\u0410\u0432\u0442\u043e\u0440 \u043f\u0440\u043e\u0432\u0435\u043b \u043f\u043e\u0438\u0441\u043a \u043d\u0430 \u0441\u0435\u0440\u0432\u0435\u0440\u0430\u0445 PubMed \u0438 \u0441\u0435\u0440\u0432\u0435\u0440\u0430\u0445 \u043f\u0440\u0435\u0434\u0432\u0430\u0440\u0438\u0442\u0435\u043b\u044c\u043d\u043e\u0439 \u043f\u0443\u0431\u043b\u0438\u043a\u0430\u0446\u0438\u0438 \u043d\u0430 \u043f\u0440\u0435\u0434\u043c\u0435\u0442 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u0439 \u0441\u0435\u0440\u043e\u0440\u0430\u0441\u043f\u0440\u043e\u0441\u0442\u0440\u0430\u043d\u0435\u043d\u043d\u043e\u0441\u0442\u0438 COVID-19 \u0441 \u0440\u0430\u0437\u043c\u0435\u0440\u043e\u043c \u0432\u044b\u0431\u043e\u0440\u043a\u0438 \u2265500 \u043f\u043e \u0441\u043e\u0441\u0442\u043e\u044f\u043d\u0438\u044e \u043d\u0430 9\u00a0\u0441\u0435\u043d\u0442\u044f\u0431\u0440\u044f 2020\u00a0\u0433\u043e\u0434\u0430. \u0411\u044b\u043b\u0438 \u0442\u0430\u043a\u0436\u0435 \u043f\u043e\u043b\u0443\u0447\u0435\u043d\u044b \u0434\u043e\u043f\u043e\u043b\u043d\u0438\u0442\u0435\u043b\u044c\u043d\u044b\u0435 \u0440\u0435\u0437\u0443\u043b\u044c\u0442\u0430\u0442\u044b \u043d\u0430\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u044b\u0445 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u0439 \u0438\u0437 \u043f\u0440\u0435\u0434\u0432\u0430\u0440\u0438\u0442\u0435\u043b\u044c\u043d\u044b\u0445 \u043f\u0440\u0435\u0441\u0441-\u0440\u0435\u043b\u0438\u0437\u043e\u0432 \u0438 \u043e\u0442\u0447\u0435\u0442\u043e\u0432. \u0410\u0432\u0442\u043e\u0440 \u043e\u0446\u0435\u043d\u0438\u043b \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u044f \u043f\u043e \u044d\u043b\u0435\u043c\u0435\u043d\u0442\u0430\u043c \u0434\u0438\u0437\u0430\u0439\u043d\u0430 \u0438 \u043e\u0446\u0435\u043d\u043a\u0430\u043c \u0441\u0435\u0440\u043e\u0440\u0430\u0441\u043f\u0440\u043e\u0441\u0442\u0440\u0430\u043d\u0435\u043d\u043d\u043e\u0441\u0442\u0438. \u0410\u0432\u0442\u043e\u0440 \u043e\u0446\u0435\u043d\u0438\u043b \u043f\u043e\u043a\u0430\u0437\u0430\u0442\u0435\u043b\u044c \u043b\u0435\u0442\u0430\u043b\u044c\u043d\u043e\u0441\u0442\u0438 \u043f\u0440\u0438 \u0438\u043d\u0444\u0438\u0446\u0438\u0440\u043e\u0432\u0430\u043d\u0438\u0438 \u0434\u043b\u044f \u043a\u0430\u0436\u0434\u043e\u0433\u043e \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u044f, \u0440\u0430\u0437\u0434\u0435\u043b\u0438\u0432 \u043e\u0431\u0449\u0435\u0435 \u043a\u043e\u043b\u0438\u0447\u0435\u0441\u0442\u0432\u043e \u0441\u043c\u0435\u0440\u0442\u0435\u0439 \u043e\u0442 COVID-19 \u043d\u0430 \u043a\u043e\u043b\u0438\u0447\u0435\u0441\u0442\u0432\u043e \u043b\u044e\u0434\u0435\u0439, \u043f\u0440\u0435\u0434\u043f\u043e\u043b\u043e\u0436\u0438\u0442\u0435\u043b\u044c\u043d\u043e \u0438\u043d\u0444\u0438\u0446\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u044b\u0445 \u0432 \u043a\u0430\u0436\u0434\u043e\u043c \u0440\u0435\u0433\u0438\u043e\u043d\u0435. \u041f\u0440\u0438 \u044d\u0442\u043e\u043c \u0431\u044b\u043b\u0430 \u0441\u0434\u0435\u043b\u0430\u043d\u0430 \u043f\u043e\u043f\u0440\u0430\u0432\u043a\u0430 \u043d\u0430 \u043a\u043e\u043b\u0438\u0447\u0435\u0441\u0442\u0432\u043e \u043f\u0440\u043e\u0442\u0435\u0441\u0442\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u044b\u0445 \u0442\u0438\u043f\u043e\u0432 \u0430\u043d\u0442\u0438\u0442\u0435\u043b\u00a0(\u0438\u043c\u043c\u0443\u043d\u043e\u0433\u043b\u043e\u0431\u0438\u043d\u044b, IgG, IgM, IgA).",
        "\u0412 \u0440\u0430\u0431\u043e\u0442\u0443 \u0432\u043e\u0448\u043b\u043e 61\u00a0\u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u0435\u00a0(74\u00a0\u043f\u0440\u043e\u0433\u043d\u043e\u0437\u0430) \u0438 \u0432\u043e\u0441\u0435\u043c\u044c \u043f\u0440\u0435\u0434\u0432\u0430\u0440\u0438\u0442\u0435\u043b\u044c\u043d\u044b\u0445 \u043d\u0430\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u044b\u0445 \u043f\u0440\u043e\u0433\u043d\u043e\u0437\u043e\u0432. \u041f\u0440\u043e\u0433\u043d\u043e\u0437\u044b \u0441\u0435\u0440\u043e\u0440\u0430\u0441\u043f\u0440\u043e\u0441\u0442\u0440\u0430\u043d\u0435\u043d\u043d\u043e\u0441\u0442\u0438 \u0432\u0430\u0440\u044c\u0438\u0440\u043e\u0432\u0430\u043b\u0438\u0441\u044c \u0432 \u0434\u0438\u0430\u043f\u0430\u0437\u043e\u043d\u0435 \u043e\u0442\u00a00,02 \u0434\u043e\u00a053,40%. \u041f\u043e\u043a\u0430\u0437\u0430\u0442\u0435\u043b\u0438 \u043b\u0435\u0442\u0430\u043b\u044c\u043d\u043e\u0441\u0442\u0438 \u043f\u0440\u0438 \u0438\u043d\u0444\u0438\u0446\u0438\u0440\u043e\u0432\u0430\u043d\u0438\u0438 \u0432\u0430\u0440\u044c\u0438\u0440\u043e\u0432\u0430\u043b\u0438\u0441\u044c \u0432 \u0434\u0438\u0430\u043f\u0430\u0437\u043e\u043d\u0435 \u043e\u0442\u00a00,00 \u0434\u043e\u00a01,63%, \u0441\u043a\u043e\u0440\u0440\u0435\u043a\u0442\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u044b\u0435 \u0437\u043d\u0430\u0447\u0435\u043d\u0438\u044f\u00a0\u2014 \u043e\u0442\u00a00,00 \u0434\u043e\u00a01,54%. \u0412 51\u00a0\u0440\u0435\u0433\u0438\u043e\u043d\u0435 \u0441\u0440\u0435\u0434\u043d\u0438\u0439 \u043f\u043e\u043a\u0430\u0437\u0430\u0442\u0435\u043b\u044c \u043b\u0435\u0442\u0430\u043b\u044c\u043d\u043e\u0441\u0442\u0438 \u043f\u0440\u0438 \u0438\u043d\u0444\u0438\u0446\u0438\u0440\u043e\u0432\u0430\u043d\u0438\u0438 COVID-19 \u0441\u043e\u0441\u0442\u0430\u0432\u0438\u043b 0,27%\u00a0(\u0441\u043a\u043e\u0440\u0440\u0435\u043a\u0442\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u044b\u0439 \u043f\u043e\u043a\u0430\u0437\u0430\u0442\u0435\u043b\u044c 0,23%): \u044d\u0442\u043e\u0442 \u043f\u043e\u043a\u0430\u0437\u0430\u0442\u0435\u043b\u044c \u0441\u043e\u0441\u0442\u0430\u0432\u0438\u043b 0,09% \u0432 \u0440\u0435\u0433\u0438\u043e\u043d\u0430\u0445 \u0441 \u0443\u0440\u043e\u0432\u043d\u0435\u043c \u043b\u0435\u0442\u0430\u043b\u044c\u043d\u043e\u0441\u0442\u0438 \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u0438\u044f \u043e\u0442 COVID-19 \u043d\u0438\u0436\u0435, \u0447\u0435\u043c \u0432 \u0441\u0440\u0435\u0434\u043d\u0435\u043c \u043f\u043e \u043c\u0438\u0440\u0443\u00a0(<118\u00a0\u0441\u043c\u0435\u0440\u0442\u0435\u0439 \u043d\u0430 \u043c\u0438\u043b\u043b\u0438\u043e\u043d), 0,20% \u0432 \u0440\u0435\u0433\u0438\u043e\u043d\u0430\u0445, \u0432 \u043a\u043e\u0442\u043e\u0440\u044b\u0445 \u0437\u0430\u0440\u0435\u0433\u0438\u0441\u0442\u0440\u0438\u0440\u043e\u0432\u0430\u043d\u043e 118\u2013500\u00a0\u0441\u043b\u0443\u0447\u0430\u0435\u0432 \u0441\u043c\u0435\u0440\u0442\u0438 \u043e\u0442 COVID-19 \u043d\u0430 \u043c\u0438\u043b\u043b\u0438\u043e\u043d \u0447\u0435\u043b\u043e\u0432\u0435\u043a, \u0438 0,57% \u0432 \u0440\u0435\u0433\u0438\u043e\u043d\u0430\u0445, \u0433\u0434\u0435 \u0437\u0430\u0440\u0435\u0433\u0438\u0441\u0442\u0440\u0438\u0440\u043e\u0432\u0430\u043d\u043e \u0431\u043e\u043b\u0435\u0435 500\u00a0\u0441\u043b\u0443\u0447\u0430\u0435\u0432 \u0441\u043c\u0435\u0440\u0442\u0438 \u043e\u0442 COVID-19 \u043d\u0430 \u043c\u0438\u043b\u043b\u0438\u043e\u043d \u0447\u0435\u043b\u043e\u0432\u0435\u043a. \u0423 \u043b\u044e\u0434\u0435\u0439 \u043c\u043b\u0430\u0434\u0448\u0435 70\u00a0\u043b\u0435\u0442 \u043f\u043e\u043a\u0430\u0437\u0430\u0442\u0435\u043b\u044c \u043b\u0435\u0442\u0430\u043b\u044c\u043d\u043e\u0441\u0442\u0438 \u043f\u0440\u0438 \u0438\u043d\u0444\u0438\u0446\u0438\u0440\u043e\u0432\u0430\u043d\u0438\u0438 \u043a\u043e\u043b\u0435\u0431\u0430\u043b\u0441\u044f \u0432 \u043f\u0440\u0435\u0434\u0435\u043b\u0430\u0445 \u043e\u0442 0,00 \u0434\u043e 0,31% \u0441 \u043f\u0440\u0438\u0431\u043b\u0438\u0437\u0438\u0442\u0435\u043b\u044c\u043d\u044b\u043c\u0438 \u0438 \u0441\u043a\u043e\u0440\u0440\u0435\u043a\u0442\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u044b\u043c\u0438 \u043c\u0435\u0434\u0438\u0430\u043d\u043d\u044b\u043c\u0438 \u0437\u043d\u0430\u0447\u0435\u043d\u0438\u044f\u043c\u0438 0,05%.",
        "\u041f\u043e\u043a\u0430\u0437\u0430\u0442\u0435\u043b\u044c \u043b\u0435\u0442\u0430\u043b\u044c\u043d\u043e\u0441\u0442\u0438 \u043f\u0440\u0438 \u0438\u043d\u0444\u0438\u0446\u0438\u0440\u043e\u0432\u0430\u043d\u0438\u0438 COVID-19 \u043c\u043e\u0436\u0435\u0442 \u0441\u0443\u0449\u0435\u0441\u0442\u0432\u0435\u043d\u043d\u043e \u0440\u0430\u0437\u043b\u0438\u0447\u0430\u0442\u044c\u0441\u044f \u0432 \u0440\u0430\u0437\u043d\u044b\u0445 \u0440\u0435\u0433\u0438\u043e\u043d\u0430\u0445, \u0438 \u044d\u0442\u043e \u043c\u043e\u0436\u0435\u0442 \u043e\u0442\u0440\u0430\u0436\u0430\u0442\u044c \u0440\u0430\u0437\u043b\u0438\u0447\u0438\u044f \u0432 \u0432\u043e\u0437\u0440\u0430\u0441\u0442\u043d\u043e\u0439 \u0441\u0442\u0440\u0443\u043a\u0442\u0443\u0440\u0435 \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u0438\u044f, \u0441\u0442\u0440\u0443\u043a\u0442\u0443\u0440\u0435 \u0441\u043b\u0443\u0447\u0430\u0435\u0432 \u0438\u043d\u0444\u0438\u0446\u0438\u0440\u043e\u0432\u0430\u043d\u0438\u044f \u0438 \u0441\u043c\u0435\u0440\u0442\u0438 \u043f\u0430\u0446\u0438\u0435\u043d\u0442\u043e\u0432, \u0430 \u0442\u0430\u043a\u0436\u0435 \u0432 \u0434\u0440\u0443\u0433\u0438\u0445 \u0444\u0430\u043a\u0442\u043e\u0440\u0430\u0445. \u041f\u0440\u0435\u0434\u043f\u043e\u043b\u0430\u0433\u0430\u0435\u043c\u044b\u0435 \u043f\u043e\u043a\u0430\u0437\u0430\u0442\u0435\u043b\u0438 \u043b\u0435\u0442\u0430\u043b\u044c\u043d\u043e\u0441\u0442\u0438 \u043f\u0440\u0438 \u0438\u043d\u0444\u0438\u0446\u0438\u0440\u043e\u0432\u0430\u043d\u0438\u0438, \u043a\u0430\u043a \u043f\u0440\u0430\u0432\u0438\u043b\u043e, \u0431\u044b\u043b\u0438 \u043d\u0430\u043c\u043d\u043e\u0433\u043e \u043d\u0438\u0436\u0435, \u0447\u0435\u043c \u043f\u0440\u043e\u0433\u043d\u043e\u0437\u044b, \u0441\u0434\u0435\u043b\u0430\u043d\u043d\u044b\u0435 \u0440\u0430\u043d\u0435\u0435 \u0432\u043e \u0432\u0440\u0435\u043c\u044f \u043f\u0430\u043d\u0434\u0435\u043c\u0438\u0438."
      ],
      "CopyrightInformation": "(c) 2021 The authors; licensee World Health Organization."
    }
  ],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33716331",
  "DateCompleted": {
    "Year": "2021",
    "Month": "03",
    "Day": "24"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "11"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "10",
        "Day": "14"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.2471/BLT.20.265892"
    ],
    "Journal": {
      "ISSN": "1564-0604",
      "JournalIssue": {
        "Volume": "99",
        "Issue": "1",
        "PubDate": {
          "Year": "2021",
          "Month": "Jan",
          "Day": "01"
        }
      },
      "Title": "Bulletin of the World Health Organization",
      "ISOAbbreviation": "Bull World Health Organ"
    },
    "ArticleTitle": "Infection fatality rate of COVID-19 inferred from seroprevalence data.",
    "Pagination": {
      "StartPage": "19",
      "EndPage": "33F",
      "MedlinePgn": "19-33F"
    },
    "Abstract": {
      "AbstractText": [
        "To estimate the infection fatality rate of coronavirus disease 2019 (COVID-19) from seroprevalence data.",
        "I searched PubMed and preprint servers for COVID-19 seroprevalence studies with a sample size \u2265\u2009500 as of 9 September 2020. I also retrieved additional results of national studies from preliminary press releases and reports. I assessed the studies for design features and seroprevalence estimates. I estimated the infection fatality rate for each study by dividing the cumulative number of COVID-19 deaths by the number of people estimated to be infected in each region. I corrected for the number of immunoglobin (Ig) types tested (IgG, IgM, IgA).",
        "I included 61 studies (74 estimates) and eight preliminary national estimates. Seroprevalence estimates ranged from 0.02% to 53.40%. Infection fatality rates ranged from 0.00% to 1.63%, corrected values from 0.00% to 1.54%. Across 51 locations, the median COVID-19 infection fatality rate was 0.27% (corrected 0.23%): the rate was 0.09% in locations with COVID-19 population mortality rates less than the global average (<\u2009118 deaths/million), 0.20% in locations with 118-500 COVID-19 deaths/million people and 0.57% in locations with >\u2009500 COVID-19 deaths/million people. In people younger than\u200970 years, infection fatality rates ranged from 0.00% to 0.31% with crude and corrected medians of 0.05%.",
        "The infection fatality rate of COVID-19 can vary substantially across different locations and this may reflect differences in population age structure and case-mix of infected and deceased patients and other factors. The inferred infection fatality rates tended to be much lower than estimates made earlier in the pandemic."
      ],
      "CopyrightInformation": "(c) 2021 The authors; licensee World Health Organization."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Meta-Research Innovation Center at Stanford (METRICS), Stanford University, 1265 Welch Road, Stanford, California 94305, United States of America."
          }
        ],
        "LastName": "Ioannidis",
        "ForeName": "John P A",
        "Initials": "JPA"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Bull World Health Organ",
    "NlmUniqueID": "7507052",
    "ISSNLinking": "0042-9686"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "mortality"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Seroepidemiologic Studies"
    }
  ]
}